40% of women have dense breasts. RESULT: Current 2D mammography makes it difficult to detect cancers in dense breast tissue because both appear white in the image. Source:

 10%-20% of women (nationally) get called back for additional imaging as a result of unclear results from 2D screening. RESULT: More expensive; additional anxiety for the patient. Source: partnership/the-reading-room/2013/09/benchmarking-screening-and- diagnostic-mammography

 Other imaging modalities like ultrasound and MRI are often used to help find cancers that can’t be seen on standard mammograms, but both modalities have higher rates of false-positive findings.  This often results in more tests and unnecessary biopsies, making MRI and ultrasound more expensive to implement in high-volume screening programs. Source:

Tomo, or 3D mammography, is a breakthrough breast cancer detection.

Tomo takes a series of images, versus 2-4 images from traditional 2D mammography. RESULT : much greater visibiliy of breast tissue structures and possible cancers.

 30-41% improved breast cancer detection, especially of invasive cancers  Up to 80% decrease in call backs for additional imaging RESULT: Reduction in healthcare costs due to earlier detection, as well as avoided follow-up testing.

“Our findings are extremely promising, showing an overall relative increase in the cancer detection rate of about 30%.” ~ Per Skaane, Oslo University Hospital, Norway Tomosynthesis not only improved the cancer detection rate in women with dense breasts, it also helped increase detection for women in the ‘fatty breast’ BI-RADS categories. Source:

“To facilitate large scale outcome data collection, the technology must be widely available. Availability is greatly impacted by reimbursement for the service provided. The College applauds the decision by the Centers for Medicare and Medicaid Services (CMS) to facilitate access to these exams by covering beneficiaries for tomosynthesis and urges private payers to do the same. ” “To be clear: tomosynthesis is no longer investigational. Tomosynthesis has been shown to improve key screening parameters compared to digital mammography. ” ACR Statement on Breast Tomosynthesis November 24,

“The addition of tomosynthesis to digital mammography yields significantly better performance outcomes when compared with screenings using digital mammography alone. “  Invasive cancer detection increased by 41%.  Patient recall rate decreased by 15%.

SDMI selected the GE SenoClaire technology because it delivers NO MORE radiation to the patient.

GE SenoClaire  No additional radiation than 2D mammo because it performs 3D and 2D imaging simultaneously. SAFER for patients! Hologic  2.4 times more radiation than 2D mammo because it conducts 2D and 3D imaging separately.

13 Reference value = EUREF limits Source: (1) Low Dose: The dose of a SenoClaire 3D view is equivalent to that of a 2D standard acquisition of the same view." (2) N.W. Marshall and H. Bosmans, Medical Physics UZ Leuven, Application of the draft EUREF protocol for Quality Control of digital breast tomosynthesis (DBT) systems”, BHPA GE SenoClaire Hologic Genius Siemens 3D Mammography SenoClaire delivers the same amount of dose as a digital mammography acquisition in the same view

Tomosynthesis is no longer considered an investigative technology. Evidence from numerous studies demonstrates the irrefutable conclusion that 3D mammography is not only better for patients with dense breasts, but ALL patients. Increased cancer detection Reduced number of call-backs and false-positives No more radiation to patient Fewer follow-up testing and biopsies Win for Patients and WIN for Teacher’s Health Trust!

Thank you for choosing SDMI as your imaging partner!